Avoid common mistakes on your manuscript.
Correction to: European Journal of Paediatrics
In the original published version of this article under the last part of the Abstract section the author made changes on their presented data the corrected data are as follows [Bold text used to highlight problem area]:
Abstract
In the sentence, "At week 14, 69% of the patients responded to the treatment (57.1% of those with UC and 75% of those with UC; p=0.238)"
The correct version should have been: "At week 14, 69% of the patients responded to the treatment (57.1% of those with CD and 75% of those with UC; p=0.238)".
The original article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The online version of the original article can be found at https://doi.org/10.1007/s00431-021-04063-6
Rights and permissions
About this article
Cite this article
Garcia-Romero, R., de Zabarte Fernandez, J.M.M., Pujol-Muncunill, G. et al. Correction to: Safety and effectiveness of vedolizumab in paediatric patients with inflammatory bowel disease: an observational multicenter Spanish study. Eur J Pediatr 180, 3039–3040 (2021). https://doi.org/10.1007/s00431-021-04117-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-021-04117-9